Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control

SK Sharma, A Mohan - Chest, 2006 - Elsevier
Multidrug-resistant tuberculosis (MDR-TB), caused by Mycobacterium tuberculosis that is
resistant to both isoniazid and rifampicin with or without resistance to other drugs, is a …

Multidrug-resistant tuberculosis

SK Sharma, A Mohan - Indian Journal of Medical Research, 2004 - repository.ias.ac.in
Multidrug-resistant tuberculosis (MDR-TB) caused by Mycobacterium tuberculosis resistant
to both isoniazid and rifampicin with or without resistance to other drugs is among the most …

The BCG experience: implications for future vaccines against tuberculosis

BR Bloom, PEM Fine - Tuberculosis: pathogenesis, protection …, 1994 - Wiley Online Library
Use of BCG (bacille Calmette‐Guérin) vaccines increased in Europe after World War II and
in develo** countries starting in the 1950s to the extent that the vaccines have now been …

The pathogenesis of tuberculosis

GAW Rook, R Hernandez-Pando - Annual review of …, 1996 - annualreviews.org
Tuberculosis patients relapse if treatment is not continued for 6 months, because
chemotherapy fails to convert the patients' response from the necrotizing pattern …

Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis

MA Skinner, S Yuan, R Prestidge, D Chuk… - Infection and …, 1997 - Am Soc Microbiol
Immune responses to Mycobacterium tuberculosis are analyzed in mice which have been
immunized with Mycobacterium vaccae to examine novel ways of altering protective …

[PDF][PDF] Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis

J Stanford, C Stanford, J Grange - Front Biosci, 2004 - academia.edu
Introduction 3. The theoretical basis of immunotherapy with Mycobacterium vaccae 3.1. The
effects on immunopathology 3.2. The evidence from skin-testing 3.3. The evidence from …

Randomized Controlled Trial of Mycobacterium vaccae Immunotherapy in Non-Human Immunodeficiency Virus-Infected Ugandan Adults with Newly Diagnosed …

JL Johnson, RM Kamya, A Okwera… - The Journal of …, 2000 - academic.oup.com
Adjunctive immunotherapy with heat-killed Mycobacterium vaccae was studied in a
randomized, placebo-controlled trial of 120 non-human immunodeficiency virus-infected …

[HTML][HTML] Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis

D Dlugovitzky, G Fiorenza, M Farroni, C Bogue… - Respiratory …, 2006 - Elsevier
We report the first study of triple-dose immunotherapy with heat-killed Mycobacterium
vaccae (SRL 172) combined with short-course, directly observed chemotherapy in newly …

Safety and Immunogenicity of a Five-Dose Series of Inactivated Mycobacterium vaccae Vaccination for the Prevention of HIV-Associated Tuberculosis

RD Waddell, C Chintu, AD Lein, A Zumla… - Clinical Infectious …, 2000 - academic.oup.com
Five doses of inactivated Mycobacterium vaccae vaccine were administered intradermally to
22 human immunodeficiency virus (HIV)—infected patients (11 bacille Calmette-Guérin …

Mycobacteria and their world

J Stanford, C Stanford - The International Journal of …, 2012 - journals.lww.com
Mycobacteria are ubiquitous, occurring everywhere in the world, except perhaps the Polar
Regions. In deserts they can be found under rocks and among the dried roots of vegetation …